Home
Edmund Dunn, Principal Accounting Officer: Monte Rosa Therapeutics GLUE Sell · Filed 03/02
Trade details
- Type
- Insider sale
- Amount
- $455,468.4
- Shares · price
- 25,164 sh · $18.10 a share
- Held after
- 22,693 sh
- Trade date
- 26/02/27
- Filed
- 26/03/02
- Days to filing
- 3 days
Sold 52.6% of holdings
- Share of holding sold
- 52.6%
Monte Rosa Therapeutics trades, last 26 weeks
What else happened in Monte Rosa Therapeutics around then
Filed or reported within 30 days of the trade day · 01/28~03/29Edmund Dunn's recent trades
- Edmund Dunn
Planned saleMonte Rosa Therapeutics
Planned saleMonte Rosa Therapeutics
GLUE
$345K
16,665 sh
$345K
Filed 06/23
Traded 06/23
- Edmund Dunn
Planned saleMonte Rosa Therapeutics
Planned saleMonte Rosa Therapeutics
GLUE
$345.6K
18,683 sh
$345.6K
Filed 04/16
Traded 04/16
- Edmund Dunn
Planned saleMonte Rosa Therapeutics
Planned saleMonte Rosa Therapeutics
GLUE
$300.4K
16,687 sh
$300.4K
Filed 04/13
Traded 04/13
- Edmund Dunn
Planned saleMonte Rosa Therapeutics
Planned saleMonte Rosa Therapeutics
GLUE
$450.6K
26,117 sh
$450.6K
Filed 04/08
Traded 04/08
- Edmund Dunn
SellMonte Rosa Therapeutics
SellMonte Rosa Therapeutics
GLUE
$2,496
139 sh
$2,496
Filed 03/05
Traded 03/04